• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

SSR240612 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5751512

SSR240612 is a potent, and orally active specific non-peptide bradykinin B1 receptor antagonist (Kis = 0.48-0.73 and 358-481nM for B1 and B2 receptors, respectively). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
SSR240612, Inhibitor
Full Product Name
SSR240612
Product Gene Name
Form/Format
Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder; -80 degree C for 2 years in solvent
For obtaining a higher solubility, please warm the tube at 37 degree C and shake it in the ultrasonic bath for a while. Stock solution can be stored below -20 degree C for several month.
Molecular Weight
793.41
Formula
C42H53ClN4O7S
CAS
464930-42-5
Smiles
Cl.COc1ccc2cc(ccc2c1)S(=O)(=O)N[C@H](CC(=O)N[C@H](Cc1ccc(CN2[C@@H](C)CCC[C@H]2C)cc1)C(=O)N(C)C(C)C)c1ccc2OCOc2c1
Receptor (IC50)
B1 Human MRC5: 0.48nM (Ki)
B1 Human HEK-B1: 0.73nM (Ki)
B2 Human CHO-B2: 358nM (Ki)
Solubility
DMSO: 100mg/mL, 126mM
Water: Insoluble
(<1mg/ml refers to the product slightly soluble or insoluble)

Structure of SSR240612, inhibitor

SSR240612 Inhibitor – Cat# MBS5751512

Product References and Citations for SSR240612, inhibitor

1. Gougat J, et al. SSR240612 [ (2R)-2-[ ((3R)-3- (1,3-benzodioxol-5-yl)-3-[[ (6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3- (4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther. 2004 May;309 (2):661-9.
2. Rodrigues-Junior VS, et al. Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice. Tuberculosis (Edinb). 2018 Mar;109:1-7.
3. Dias JP, et al. The kinin B1 receptor antagonist SSR240612 reverses tactile and cold allodynia in an experimental rat model of insulin resistance. Br J Pharmacol. 2007 Sep;152 (2):280-7.

Other Notes

Small volumes of SSR240612, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for SSR240612 purchase

MBS5751512 is an inhibitor targeting SSR240612.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000